Abcuro Secures $200M Series C to Advance Ulviprubart for IBM
Key Highlights Abcuro raises $200M in Series C funding led by New Enterprise Associates (NEA) with participation from…
Browsing Tag
BlackRock
2 posts
Genesis Therapeutics Closes Oversubscribed $200 Million Series B Financing
Genesis Therapeutics, a pioneer in integrating artificial intelligence (AI) technologies for the development of innovative medicines for patients…